Company
Headquarters: Taipei, Taiwan
TW$1.45 Billion
TWD as of Jan. 1, 2024
US$47.2 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Come True Biomedical Inc. engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One that is a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; Max Care antrodia and turmeric capsules; and Max Care natto monascus capsules, as well as other nutritional products under the King One name. It also provides genetic testing services. In addition, the company offers energy and dual-purpose mattresses, energy masks, energy silicon gel necklaces, energy waistbands, energy heating stones, massage rods, and water purifiers, as well as Ganbanyoku, an energy stone spa bed. Further, it provides beauty care products, such as hydration, cell rejuvenation, GHK-CU, and restoration series skin care products, as well as home energy products, and microcontrollers and peripherals. The company was formerly known as Topro Technology Inc. and changed its name to Come True Biomedical Inc. in June 2014. Come True Biomedical Inc. was founded in 1997 and is headquartered in Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Come True Biomedical, Inc. has the following listings and related stock indices.
Stock: TWSE: 6236 wb_incandescent